Link Health and George Clinical to establish clinical development company 30 Apr 2021 (Last Updated April 30th, 2021 17:42)
Guangzhou Link Health Pharma and George Clinical have signed a term sheet to enter a strategic agreement to launch a clinical development company to deliver trials.
Share Article
George Clinical will lead the operations of Link-George, with a board that has representatives from both Link Health and George Clinical. Credit: mwooten from Pixabay.
Guangzhou Link Health Pharma and George Clinical have signed a term sheet to enter a strategic agreement to launch a clinical development company to deliver trials.
The new independent joint venture company called Link-George Clinical Research will deliver clinical trials for Link Health and associated firms with which it has signed licensing deals.
Link Health and George Clinical Create New Mode of Pharmaceutical Research and Development in China forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Elective surgeries resume at Mediclinic George Mediclinic Southern Africa said last week that vaccinators are currently undergoing online training to ensure that the hospital group complies with all regulations relating to the roll-out of Covid-19 vaccinations. Journalist Monday, 01 February 2021, 12:29 The decline in Covid cases admitted to Mediclinic George has enabled the hospital to resume elective surgery. Photo: Alida de Beer
GEORGE NEWS - Mediclinic George is able to resume elective surgeries today, 1 February, due to the continuing decline in Covid-19 cases. We are fortunately seeing a reduction in cases and admissions and are happy that we can also reintroduce visiting hours, but only one visitor at a time. Covid patients are not allowed to receive any visitors, said the manager, Kassie Karstens.
Oncologist Herbert Loong Joins George Clinical Scientific Leadership
News provided by
Share this article
Share this article
OVERLAND PARK, Kan., Jan. 18, 2021 /PRNewswire/ Herbert Loong, MBBS, PDipMDPath, MRCP (UK), FRCP Edin, FHKCP, FHKAM (Medicine), an oncologist and clinical researcher based in Hong Kong, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization.
Dr. Loong holds conjoint appointments of Clinical Assistant Professor in the department of clinical oncology and Deputy Medical Director of the Phase 1 Clinical Trials Center of The Chinese University of Hong Kong. He is also the current and founding convenor of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team.